1-4 of 4
Rushir Choksi
Close
Sort by
Journal Articles

A Patient-Centered Programmatic Approach for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the US Community Oncology Setting

James M. Rossetti, Rushir Choksi, Anupama Vasudevan, Simon Blanc, Dawn Brenneman, Brandon Wang, Peter McMahon, Jason Beal, Teraneh Z. Jhaveri, Mellissa Williamson, Cosmina Hogea
Journal: Blood
Blood (2023) 142 (Supplement 1): 5101.
https://doi.org/10.1182/blood-2023-186836
Published: 2023
Journal Articles

An Analysis of Ruxolitinib Dosing for Myelofibrosis in Real-World Practice

James M. Rossetti, Rushir Choksi, Purvi Suthar, Phoebe Davis, Anupama Vasudevan, Poras Dave, Varun Vaidya, Brandon Wang, Harvey I. Katzen
Journal: Blood
Blood (2023) 142 (Supplement 1): 5186.
https://doi.org/10.1182/blood-2023-179402
Published: 2023
Journal Articles

Assessing Adoption of Standard of Care and Comparing Clinical and Demographic Differences in First-Line (1L) Treatment (Tx) of Chronic Lymphocytic Leukemia (CLL)

Jing-Zhou Hou, Michael Gart, Anupama Vasudevan, Harvey I. Katzen, Rushir Choksi, Simon Blanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 130.
https://doi.org/10.1182/blood-2023-178685
Published: 2023
Journal Articles

Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Patterns Among Patients with Chronic or Small Lymphocytic Leukemia (CLL/SLL) in US Community Oncology Practices

Jing-Zhou Hou, Simon Blanc, Gregory A Maglinte, Anupama Vasudevan, Anna Rui, Michael Gart, Hoa Pham, Lindsay Aton, Brandon Wang, Rushir Choksi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5163.
https://doi.org/10.1182/blood-2023-174915
Published: 2023